We are live on ! Find out more
CLOV icon

Clover Health Investments

137 hedge funds and large institutions have $71.1M invested in Clover Health Investments in 2024 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 39 increasing their positions, 35 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more call options, than puts

Call options by funds: $2.22M | Put options by funds: $1.33M

11% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 35

2.26% less ownership

Funds ownership: 24.35%22.09% (-2.3%)

5% less funds holding

Funds holding: 144137 (-7)

23% less capital invested

Capital invested by funds: $92.7M → $71.1M (-$21.6M)

25% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 20

Holders
137
Holders Change
-7
Holders Change %
-4.86%
% of All Funds
1.97%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
15
Increased
39
Reduced
35
Closed
20
Calls
$2.22M
Puts
$1.33M
Net Calls
+$891K
Net Calls Change
-$1.67M
Name Holding Trade Value Shares
Change
Change in
Stake
SOW
26
State of Wyoming
Wyoming
$366K +$63.5K +69,759 +18%
CS
27
Credit Suisse
Switzerland
$323K +$30.2K +33,156 +9%
California State Teachers Retirement System (CalSTRS)
28
California State Teachers Retirement System (CalSTRS)
California
$271K +$5.27K +5,794 +2%
GCP
29
GSA Capital Partners
United Kingdom
$244K +$51.1K +56,138 +22%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$226K -$114K -125,106 -31%
State of Wisconsin Investment Board
31
State of Wisconsin Investment Board
Wisconsin
$225K -$30.6K -33,683 -11%
SRC
32
Sage Rhino Capital
California
$208K
Legal & General Group
33
Legal & General Group
United Kingdom
$202K -$14.3K -15,768 -6%
UBS Group
34
UBS Group
Switzerland
$193K +$107K +117,503 +94%
Osaic Holdings
35
Osaic Holdings
Arizona
$189K -$23.3K -25,555 -10%
Truist Financial
36
Truist Financial
North Carolina
$144K -$27.6K -30,355 -14%
FL
37
FreeGulliver LLC
Louisiana
$143K +$118K +130,000 +260%
BCM
38
Bayesian Capital Management
New York
$142K +$163K +179,000 New
Commonwealth Equity Services
39
Commonwealth Equity Services
Massachusetts
$142K -$11.8K -12,923 -7%
PAS
40
Point72 Asia (Singapore)
Singapore
$137K +$141K +154,650 +883%
TCWA
41
Turtle Creek Wealth Advisors
Texas
$135K
VOYA Investment Management
42
VOYA Investment Management
Georgia
$130K +$28K +30,736 +23%
Group One Trading
43
Group One Trading
Illinois
$123K +$75.6K +83,120 +116%
UBS AM
44
UBS AM
Illinois
$113K
SAM
45
SignalPoint Asset Management
Missouri
$111K +$36.4K +40,000 +40%
Janus Henderson Group
46
Janus Henderson Group
United Kingdom
$109K +$17 +19 +0%
Baird Financial Group
47
Baird Financial Group
Wisconsin
$106K
Bank of America
48
Bank of America
North Carolina
$95K -$194K -213,120 -64%
Squarepoint
49
Squarepoint
New York
$92.9K -$60.5K -66,470 -36%
Credit Agricole
50
Credit Agricole
France
$92.1K

CLOV Hedge Fund Activity: Q1 2024 in Review

137 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Clover Health Investments (CLOV) for Q1 2024, worth a combined $71.1M — down 23% from $92.7M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of CLOV and 15 opened new positions — a net loss of 5 holders — while 35 trimmed existing stakes and 39 added.

The largest buyer was BlackRock, adding an estimated $1.81M. The largest seller was Vanguard Group, cutting an estimated $6.04M.

  • 137 institutional investors held Clover Health Investments (CLOV) as of Q1 2024, down from 144 in Q4 2023.
  • Funds reported $71.1M of Clover Health Investments stock for Q1 2024, down 23% quarter-over-quarter.
  • 15 funds opened new Clover Health Investments positions in Q1 2024 and 20 closed out, a net change of -5 holders.
  • The largest Clover Health Investments buyer in Q1 2024 was BlackRock, an estimated $1.81M added.
  • The largest Clover Health Investments seller in Q1 2024 was Vanguard Group, an estimated $6.04M sold.

Based on aggregated 13F filings for Q1 2024.